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Abstract
Dry eye disease can cause ocular surface inflammation that disrupts the corneal epithelial barrier. While dry eye patients are
known to have an increased risk of corneal infection, it is not known whether there is a direct causal relationship between
these two conditions. Here, we tested the hypothesis that experimentally-induced dry eye (EDE) increases susceptibility to
corneal infection using a mouse model. In doing so, we also examined the role of surfactant protein D (SP-D), which we
have previously shown is involved in corneal defense against infection. Scopolamine injections and fan-driven air were used
to cause EDE in C57BL/6 or Black Swiss mice (wild-type and SP-D gene-knockout). Controls received PBS injections and were
housed normally. After 5 or 10 days, otherwise uninjured corneas were inoculated with 109 cfu of Pseudomonas aeruginosa
strain PAO1. Anesthesia was maintained for 3 h post-inoculation. Viable bacteria were quantified in ocular surface washes
and corneal homogenates 6 h post-inoculation. SP-D was measured by Western immunoblot, and corneal pathology
assessed from 6 h to 4 days. EDE mice showed reduced tear volumes after 5 and 10 days (each by ,75%, p,0.001) and
showed fluorescein staining (i.e. epithelial disruption). Surprisingly, there was no significant difference in corneal pathology
between EDE mice and controls (,10–14% incidence). Before bacterial inoculation, EDE mice showed elevated SP-D in
ocular washes. After inoculation, fewer bacteria were recovered from ocular washes of EDE mice (,2% of controls,
p = 0.0004). Furthermore, SP-D knockout mice showed a significant increase in P. aeruginosa corneal colonization under EDE
conditions. Taken together, these data suggest that SP-D contributes to corneal defense against P. aeruginosa colonization
and infection in EDE despite the loss of barrier function to fluorescein.
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Introduction
Bacterial keratitis is a severe, vision-threatening disease of the
cornea associated with contact lens wear or ocular injury [1]. To
this end, bacterial keratitis research has mostly focused on contact
lens-wearing patient populations [2], or involved animal models of
keratitis in which the cornea is either scratch-injured to allow
infection or less commonly fitted with a contact lens [3–6]. These
types of studies have helped identify numerous bacterial and host
immune events that are important for disease pathogenesis, and
have highlighted the resilience of the healthy ocular surface against
infection. While other ocular surface diseases have also been
associated with microbial keratitis, e.g. keratopathies [7] or dry eye
diseases [8], little is known of the mechanisms involved.
The estimated prevalence of dry eye disease among microbial
keratitis cases varies with study design, ranging from 7–15% in
patients seeking treatment in a hospital or eye clinic setting [8–10],
and up to 26% of patients dwelling in convalescent homes [11,12].
Causative agents are mostly well-recognized opportunistic ocular
pathogens such as coagulase-negative Staphylococcus spp., S. aureus,
Corynebacterium spp. Streptococcus pneumoniae, and Pseudomonas aerugi-
nosa [11]. Specific changes in the tear film composition have been
reported that suggest dry eye disease patients may be compro-
mised in defenses against microbial colonization. For example, a
hallmark of dry eye inflammation in Sjo¨gren’s Syndrome is the
depletion of conjunctival goblet cells which normally produce
copious amounts of a gel-forming mucins MUC5A and MUC19
[13,14], which trap bacteria and facilitate their clearance [15].
Dry eye patient tear samples also have been reported to differ in
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the relative abundance of antimicrobial factors including lyso-
zyme, lactoferrin, lipocalin, MUC1, MUC4, MUC16, and beta-
defensins [16–21]. Proinflammatory cytokines, e.g. IL-1b, are
elevated in patients with dry eye disease as are matrix
metalloproteinases such as MMP-9 [22]. Similar results have
been obtained in experimentally-induced dry eye (EDE) animal
models [23,24], and associated with changes in the structural
integrity of the corneal epithelium [25,26]. More recently, the
proinflammatory cytokine IL-17 was shown to be important in the
pathogenesis of EDE [27,28]. Recent studies have also shown an
upregulation of secretory phospholipase A2 (sPLA2-IIa), an
inflammatory disease biomarker and mediator, in patients with
dry eye disease and in EDE [29,30]. However, it is not yet known
if one or more of these tear and corneal epithelial changes
associated with dry eye disease or EDE predispose the cornea to
infection.
Several of our previous studies using P. aeruginosa have
highlighted the importance of tear fluid in protecting the cornea
from infection. These include direct effects of tear fluid on
bacteria, preventing invasion, cytotoxicity and epithelial traversal
[31,32], and indirect effects of tears by induction of corneal
epithelial antimicrobial and immunomodulatory factors, e.g.
RNase7 and ST-2 [33]. Our other previous studies have also
shown the importance of surfactant protein-D, found in tear fluid
and the corneal epithelium, in helping the ocular surface defend
against P. aeruginosa and its pathogenic mechanisms [34–36]. Here,
we tested the hypothesis that EDE would alter corneal suscepti-
bility to P. aeruginosa colonization and infection in vivo. Our results
showed that the murine cornea retained its resistance to P.
aeruginosa infection under EDE conditions, and part of that
resistance was associated with the increased expression of SP-D.
Materials and Methods
Ethics Statement
All procedures involving animals were carried out in accordance
with standards established by the Association for the Research in
Vision and Ophthalmology, and under a protocol approved by the
Animal Care and Use Committee, University of California,
Berkeley, an AAALAC accredited institution.
Experimentally-Induced Dry Eye (EDE) Murine Model
EDE was induced in female, 6–8 weeks old C57BL/6 mice
(Charles River Laboratories, Boston, MA), or in female or male 6–
8 weeks old SP-D gene knockout (sp-d 2/2) Black Swiss mice (a
generous gift of Dr. Samuel Hawgood, University of California,
San Francisco) along with strain/age/sex-matched controls
(Taconic Farms, Cambridge City, IN). Mice were given subcuta-
neous injections of scopolamine hydrobromide (0.2 mL of
2.5 mg/mL per 20 g body weight; Sigma-Aldrich, St. Louis,
MO) 3 times daily, alternating between right and left flanks, as
previously described [37]. Animals were housed in mesh-sided
cages, exposed to continuous fan-generated air drafts of low
humidity (35–40%) for a period of 5 or 10 days. Control mice
received vehicle only (PBS) injections and were housed under
standard vivarium conditions without air drafts and normal
humidity (40–50%). Aqueous tear production was assessed by
placing a cotton thread (Zone Quick; FCI Ophthalmics, Marsh-
field, MA) in the lateral canthus for 30 s as previously described
[26], and was reported as millimeters of wetted thread. When
appropriate animals were anesthetized with intraperitoneal
injections of 1.5 mg ketamine, 0.17 mg xylazine, 21 mg acepro-
mazine per 20 g body weight. All mice (C57BL/6 or Black Swiss)
developed similar levels of EDE. At the conclusion of each
experiment, tissue samples were collected from euthanized
animals.
Fluorescein Staining
The corneas of anesthetized mice were topically infused with
3 mL of a sterile sodium fluorescein suspension (100 mL PBS rinse
of a Fluoret stick; Chavvin, Aubenas, FR) for 3 min. Excess
fluorescein was removed by washing with 1 mL of PBS. Corneal
staining was observed under 206magnification with a dissecting
stereomicroscope (Zeiss, Jena, Germany) equipped with a blue
light illumination, and documented with a AxioCam MR (Zeiss,
Jena, Germany).
Bacterial inoculation and quantification
P. aeruginosa strain PAO1 (serogroup O5) was used for this study.
PAO1 is able to invade corneal epithelial cells and is virulent in a
scarified murine cornea [38]. Bacteria were grown on Trypticase
soy agar (TSA) at 37uC for 16 h and then resuspended in sterile
phosphate-buffered saline (PBS) to a concentration of 1011 cfu/
mL. Bacterial concentrations were confirmed by quantitative
plating on TSA for viable counts. Following 5 or 10 day course of
EDE induction or control treatments, ocular surfaces of anesthe-
tized mice were inoculated topically with 5 mL containing 109 cfu
bacteria without introducing mechanical injury. Mice were
maintained under sedation for the initial phase of the challenge
,3 h. At various times after inoculation, viable bacteria in tear
fluids or corneal tissues were assessed using quantitative plating on
TSA [36].
Ocular Surface Washes, Corneal Homogenates and
Determination of Ocular Pathology
Murine tear fluids were harvested by washing the ocular surface
of anesthetized mice with 5 mL of sterile PBS and collecting the
washes with sterile, glass microcapilliary tubes (10 mL; Drummond
Scientific Inc, Broomall, PA) placed in the lateral canthus. These
ocular surface washes (2 mL) were serially diluted and plated for
viable bacteria. To prepare corneal homogenates, eyes were
collected from euthanized animals, corneal tissues were harvested
ex situ and washed extensively with PBS (10 mL). The corneas
were homogenized in 100 mL PBS containing 0.25% Triton X-
100 with sterile Kontes microtube pellet pestle (Daigger, Vernon
Hills, IL) and sampled for viable bacteria. Corneal pathology was
assessed at various times pre- and post-inoculation, and docu-
mented with a digital CCD camera (Optronics, Goleta, CA)
stereomicroscope system (Stemi 2000-C; Carl Zeiss, Thornwood,
NY). Pathology was scored on 5-point grading system (0–4) based
on the amount of surface area involved, the density of an opacity,
and the overall surface regularity similar to that previously
described [38]. Scores ranged from 0 (no infection) to a maximum
of 12 (severe infection).
SP-D Detection
SP-D in murine tear fluids was detected by Western Immuno-
blot as described previously [35]. Tear fluids were collected by
washing the ocular surface with PBS as described above and
pooling samples from 10 mice per group. Total protein
concentration of pooled ocular surface washes was determined
with a BCA assay (Pierce, Rockford, IL), and equivalent amounts
of protein resolved by SDS-PAGE (Tris-HCl Ready Gel 10%,
BioRad, Hercules, CA) under denaturing conditions. Proteins
were transferred to nitrocellulose by electroblotting (180 mAmps
for 2 h) in transfer buffer (25 mM Tris, 190 mM glycine, and 10%
(v/v) methanol). Membranes were blocked with a solution of 10%
Dry Eye Disease and Defense against P. aeruginosa
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dry-skim milk suspended in PBS containing 0.1% Tween-20 (PBS-
T) for 3 h at room temperature. Primary antibody solution
contained rabbit anti-SP-D IgG (generous gift of Dr. Samuel
Hawgood, University of California, San Francisco) diluted 1:750
in PBS-T (4uC for 10 h). After washing thoroughly with PBS-T, a
secondary antibody solution was used consisting of anti-rabbit
IgG-horseradish peroxidase conjugate (BioRad) diluted 1:3,000 in
PBS-T (room temperature for 1 h). After PBS-T washing,
membranes were visualized with a chemiluminescence substrate
(Western Lighting ECL, Perkin Elmer, Waltham, MA) and
imaging system (FluorChem, Alpha Innotech, Santa Clara, CA).
Statistical Analysis
Tear volume analysis involved repeated samples on the same
animals were thus compared using a parametric repeated
measures ANOVA and Bonferroni post-test. Viable bacterial
counts were compared using a nonparametric Mann-Whitney t-
Test. Incidences of bacterial infections were compared by Chi
square analysis. P values,0.05 were considered significant. All
experiments were repeated at least once.
Results
EDE Mice Show Similar P. aeruginosa Tissue Colonization
and Pathology to Controls
EDE was induced in C57BL/6 mice for 5–10 days as described
previously [26,37]. This model is known to induce damage in the
lacrimal gland, cornea, and conjunctiva without grossly affecting
other mucosal and non-mucosal tissues [39,40]. As previously
reported [37], we observed a significant decrease in tear volume
(,70%) compared to control mice within the first 2 days of
administering scopolamine and evaporative air drafts, and this
decrease was maintained for 10 days (Fig. 1A). EDE mice also
showed fluorescein penetration of the cornea after 5 days, which
intensified up to 10 days with continued scopolamine and air draft
exposure (Fig. 1B, lower panels). Control mice did not show
significant fluorescein staining (Fig. 1B, upper panels). After 10
days of EDE, mice were topically challenged with P. aeruginosa
strain PAO1 (,109 cfu) without other prior injury to the cornea.
Dry eye conditions were maintained and ocular pathology
observed for up to 4 days (96 h) post-inoculation (pi). After 4
days, there were relatively few instances of ocular pathology. Less
than 15% of challenged corneas displayed pathology, and there
was no significant difference in disease incidence between EDE
and control mice [EDE 14% versus control 10%; p-value (Chi
square) = 0.75] (Table 1). When present, corneal pathology
manifested as focal or punctate opacities observed within 24 h of
challenge and varied from mild to moderate severity with disease
scores of 4, 5, and 6, Table 1) after 4 days.
Enhanced P. aeruginosa Clearance From Ocular Surface
Washes of EDE Mice
The initial clearance of P. aeruginosa from the ocular surface was
assessed by measuring viable bacteria in corneal homogenates and
ocular surface washes of EDE mice compared to normal controls
at 6 h post-inoculation. EDE was induced for 5 days before
bacterial inoculation. The majority of the P. aeruginosa inoculum
(.99.9%) was rapidly cleared from the ocular surface (corneal
homogenates and ocular surface washes) of both EDE and control
mice after 6 h (Fig. 2). This was consistent with our previous
studies using a similar ‘‘null infection’’ model [36,41]. EDE and
control mice were not significantly different with respect to
bacterial numbers in corneal homogenates after 6 h (Fig. 2A).
However, there was a significant reduction (,50-fold) in the
number of viable bacteria recovered from ocular surface washes of
EDE mice compared to controls after 6 h (Fig. 2B, p = 0.049,
Mann-Whitney test) showing that EDE enhanced the ocular
clearance of P. aeruginosa.
Increased Expression of SP-D in Ocular Surface Washes of
EDE Mice
We have previously shown that SP-D, a member of the collectin
family of innate defense molecules, is present in tear fluid and the
corneal epithelium and plays a role in ocular defense against P.
aeruginosa [34,36]. Thus, SP-D levels were assessed in EDE mice
and controls after 5 days of EDE induction, and before and after
(6 h) inoculation with 109 cfu PAO1. To account for differences in
tear volume, equivalent amounts of total protein from each sample
Figure 1. Induction of experimental dry eye. Tear volumes (A) and
fluorescein staining (B) in the eyes of C57BL/6 mice under experimental
dry eye (EDE) conditions versus normal controls (NC). (A) EDE resulted in
significant decreases in tear volume after 2 days. Tears were collected
from the lateral canthus using cotton thread and reported as
millimeters of wetted thread. Data are expressed as the mean +/2
standard deviation per group from three independent experiments ($3
mice per group for each experiment). * Denotes significance differences
between treatment groups (determined with a parametric repeated
measures ANOVA and Bonferroni post-test), p,0.001 in each instance).
(B) Corneal integrity was assessed by fluorescein staining in EDE mice or
normal controls after 5 or 10 days. Eyes were examined under blue light
illumination at 20-x magnification. Photographs are representative of
three independent experiments ($3 mice per group for each
experiment). Control mouse eyes are shown in the upper panels (a,
b), EDE mouse eyes are shown in the lower panels (c, d). Arrows denote
regions of fluorescein staining on the ocular surface.
doi:10.1371/journal.pone.0065797.g001
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were used for analyses. EDE mice showed increased expression of
SP-D in ocular surface washes compared to normal controls prior
to bacterial inoculation (Fig. 3). This difference was not seen the
post-inoculation ocular surface washes, although the latter samples
did contain an additional form of SP-D which we have also
observed in a previous study [34]. The antibody against SP-D did
not react with bacteria alone. These data show that EDE also
increases expression of SP-D at the murine ocular surface.
EDE Increases P. aeruginosa Corneal Colonization in SP-D
Deficient Mice
Although EDE enhanced SP-D expression in ocular washes of
normal mice prior to bacterial challenge, normal mice had
previously shown no difference in ocular colonization between
normal and EDE conditions. Thus, SP-D deficient (sp-d 2/2)
mice were tested for P. aeruginosa corneal colonization under EDE
conditions. Since sp-d gene knockout mice were available in a
Black Swiss background, a control colonization experiment was
done using wild-type Black Swiss mice. EDE did not affect corneal
colonization by P. aeruginosa in wild-type Black Swiss mice (Fig. 4A),
consistent with our earlier results from wild-type C57BL/6 mice
(Fig. 2A). SP-D deficient mice were also exposed to EDE or
normal conditions (NC) for 5 days then challenged with 109 cfu of
P. aeruginosa strain PAO1. A significant increase in bacterial
corneal colonization (,5-fold) was observed in SP-D deficient
mice under EDE compared to normal conditions at 6 h (Fig. 4B).
Thus, without SP-D, EDE is associated with increased P. aeruginosa
corneal colonization.
Discussion
Dry Eye Disease is denoted by low tear volumes and
inflammatory damage to the conjunctiva and/or cornea [42]. As
such, dry eye disease has the potential to increase susceptibility to
infection. The results of the present study, however, show that
induction of dry eye disease in a murine experimental model
(EDE) did not increase corneal susceptibility to P. aeruginosa
infection with minimal pathology observed in both normal and dry
eye mice. The data also showed that EDE resulted in an increase
in surfactant protein-D expression at the ocular surface (ocular
surface washes) before bacterial inoculation, and this correlated
with increased bacterial clearance from the tears (ocular surface
Table 1. Incidence and severity of P. aeruginosa infections in EDE mice.
Treatment Group Incidence of Pathology Pathology Scores Chi-square Value
Control 1 (10 mice) 6 0.75
EDE 2 (14 mice) 4, 5
C57BL/6 mice were exposed to EDE or control conditions for 10 d prior to topical challenge with 109 cfu of P. aeruginosa strain PAO1. Mice were monitored for corneal
infiltrates, opacities, and changes in epithelial surface regularity. Pathology was graded at 96 h post-inoculation (see Materials and Methods). Incidences of pathology in
EDE and control groups were not significantly different (Chi-square analysis). Data is representative of two independent experiments.
doi:10.1371/journal.pone.0065797.t001
Figure 2. Ocular clearance of P. aeruginosa in EDE. Levels of viable P. aeruginosa (cfu) in corneal homogenates (A) or ocular surface washes (B) of
C57BL/6 EDE mice compared to normal controls (NC) at 6 h post-inoculation with 109 cfu of P. aeruginosa strain PAO1 (T = 0). EDE was induced for 5
days prior to bacterial inoculation. Bacteria were rapidly cleared from the murine ocular surface of both groups of mice after 6 h. Similar bacterial
levels were found in corneal homogenates (A), but fewer bacteria were recovered from the ocular surface washes of EDE mice compared to controls
(p = 0.049, Mann-Whitney test) (B). Data are representative of three independent experiments ($5 animals per group in each experiment). Data for
each sample are shown as the median (black square) with upper and lower quartiles (boxed area), and range of the data (error bars).
doi:10.1371/journal.pone.0065797.g002
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washes) of EDE mice. While corneal colonization was unaffected
by dry eye disease in wild-type mice, our data showed that sp-d
gene knockout mice showed increased corneal colonization under
EDE conditions. Together these data show that dry eye disease
does not compromise ocular defenses against P. aeruginosa infection,
and suggest that SP-D contributes to ocular defense against
infection under EDE conditions.
Upregulation of SP-D in ocular surface washes in response to
dry eye conditions may reflect a compensatory innate defense
response. This would be consistent with previous studies which
have suggested that other ocular innate defenses are upregulated
in patients with dry eye disease including membrane-associated
mucins (e.g. MUC1) [21,43] and human beta-defensins [18,19].
SP-D has antimicrobial, aggregative and opsonizing properties
against P. aeruginosa, it is present in tear fluid, inhibits P. aeruginosa
internalization by corneal epithelial cells, and it promotes ocular
clearance of P. aeruginosa in vivo [34,36,44–47]. Each of these
protective effects could help provide enhanced defense of the
ocular surface from infection during dry eye disease, more so if
combined with antimicrobial and anti-adhesive actions of other
innate defenses, e.g. defensins and mucins respectively [41,48,49].
In our study, enhanced SP-D expression in ocular surface washes
of dry eye mice correlated with reduced numbers of viable bacteria
in those washes. However, further studies will be needed to
determine the relative role(s) of SP-D, and other ocular surface
antimicrobial defenses that are likely to be upregulated, in
removing P. aeruginosa from the ocular surface under the dry eye
conditions in this model.
The mechanism for SP-D upregulation in ocular washes of EDE
mice is not yet known. We have previously shown that P. aeruginosa
flagellin and LPS antigens can each upregulate SP-D production
and secretion in corneal epithelial cells, the latter through a
mechanism involving JNK [35]. However, upregulation in dry eye
mice occurred before bacterial inoculation. Thus, other facets of
dry eye disease must trigger increased SP-D expression at the
ocular surface. Mechanisms of SP-D expression and upregulation
in various mammalian cells are complex and incompletely
understood [35,50,51]. However, dry eye disease in murine
models or humans is known to involve increased expression of
Figure 3. SP-D expression in EDE before and after P. aeruginosa
challenge. Western immunoblot blot analysis of SP-D expression in
pooled ocular surface washes from EDE and control mice (10 mice per
group) after 5 days EDE induction, and before and 6 h after inoculation
with P. aeruginosa strain PAO1 (109 cfu). To normalize for differences in
tear volume, equivalent amounts of protein (2 mg) were used in the
analysis (BCA protein assay). Purified recombinant SP-D (rSP-D,,43 kDa
monomer), and a relevant number of bacteria suspended in PBS
(56103 cfu, see Fig. 2B), were included as positive and negative
controls, respectively. SP-D expression in ocular surface washes was
increased under EDE conditions before bacterial inoculation. The
experiment was repeated once.
doi:10.1371/journal.pone.0065797.g003
Figure 4. Effect of EDE on P. aeruginosa corneal colonization in SP-D knockout mice. Corneal colonization by P. aeruginosa in normal Black
Swiss mice (A) or SP-D deficient age/sex-matched Black Swiss mice (B) under normal (NC) and experimental dry eye (EDE) conditions. After 5 days EDE
induction, otherwise uninjured corneas were challenged with 109 cfu of P. aeruginosa strain PAO1 (T = 0). EDE did not affect bacterial colonization in
wild-type mice after 6 h. However, EDE in SP-D knockout mice (sp-d2/2) resulted in a,5-fold increase in corneal colonization after 6 h. Data shown
is representative of two independent experiments with SP-D-deficient Black Swiss mice (n$5 animals per group). P values were obtained using the
Mann-Whitney Test. Data for each sample are shown as the median (black square) with upper and lower quartiles (boxed area), and range of the data
(error bars).
doi:10.1371/journal.pone.0065797.g004
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proinflammatory mediators such as IL-1b, IL-6, IL-8, and involve
MAP kinase signaling proteins including JNK [22,52–54]. SP-D is
also known as an immuno-modulator with sp-d knockout mice
showing enhanced inflammatory-mediated tissue pathology in the
cornea and other animal infection models [47,55]. It is possible,
therefore, that increased SP-D expression in EDE occurs in
response to ocular inflammation, and that it functions to modulate
those responses and protect against bacterial challenge.
Two different mouse strains were used in this study (C57BL/6
and Black Swiss). We are unaware of any differences in SP-D
expression between these and other mouse strains. Black Swiss
mice show a bias towards Th2 responses, and a SP-D knockout
mouse in that strain could show greater Th2 responsiveness, as
shown in models of lung allergy [56]. It has been also shown that
BALB/c mice (which also show a TH2 bias) produce lower levels
of pro-inflammatory cytokines and display less severe changes in
goblet cell density under EDE conditions compared to C57BL/6
mice which have a TH1 bias [57]. However, further studies will be
needed to determine the relationship, if any, between different
mouse strains, SP-D expression, and P. aeruginosa colonization
under EDE conditions.
In conclusion, experimental dry eye mice were not inherently
more susceptible to P. aeruginosa infections than controls. These
animals were able to displace bacteria from the ocular surface and
displayed relatively low incidence rates of mild to moderate
pathology, comparable to normal controls. Although dry eye
disease in this model can promote desquamation of the superficial
corneal epithelial cells, decrease the relative number of intercel-
lular tight junctions [25,26], it is recognized that other protective
defenses can be upregulated in dry eye including pro-inflamma-
tory mediators, defensins and mucins. Our data shows that SP-D is
also upregulated in dry eye conditions, and may contribute to
ocular resistance to infection during desiccating stress.
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